Hyndiuk R A, Schultz R O
Department of Ophthalmology, Medical College of Wisconsin, Milwaukee 53226.
Lens Eye Toxic Res. 1992;9(3-4):331-50.
Surgical solutions and drugs are important in ocular surgery. These include irrigating solutions, viscoelastic substances, mydriatics and miotics, and a growing number of other agents designed to enhance intraocular surgery and its outcome. Potential for damage to the corneal endothelium and other tissues is related to the chemical composition, pH, and osmolality of the irrigating solutions that bathe tissues. Quality balanced salt solutions (BSS) are usually safe for use as an intraocular solution in patients with normal corneal endothelium. If prolonged irrigation times are expected, or the patient already has decompensated endothelium, i.e., primary or secondary endotheliopathy, the use of a "complete" BSS solution is indicated to minimize damage. Intraocular sulfite-containing epinephrine may cause severe corneal edema and should be avoided, or if used, be well diluted. Sulfite-free epinephrine solution is now available and does not cause the endothelial toxicity that one may see with sulfite-containing epinephrine solutions. Current formulations of acetylcholine and carbachol used as miotics in surgery have been evaluated in humans and caution is recommended in using acetylcholine solutions intracamerally in patients with already decompensated endothelium. Chondroitin sulfate, hydroxypropyl methylcellulose, and sodium hyaluronate are non-toxic to animal endothelial cells under conditions analogous to cataract extraction in humans but can be toxic to endothelium if there is continued contact with endothelium for hours. Chondroitin sulfate has been shown to have more of a protective effect in mechanical pseudophakos trauma probably because of its cohesiveness and tendency to coat the endothelium. Viscoelastics cause a significant rise in intraocular pressure of > 30 mm Hg in 3-10% of patients. Very high intraocular pressures are often seen postoperatively after viscoelastic use surgically in patients who preoperatively have a history of ocular hypertension or glaucoma.
手术解决方案和药物在眼科手术中很重要。这些包括冲洗液、粘弹性物质、散瞳剂和缩瞳剂,以及越来越多旨在改善眼内手术及其效果的其他药物。对角膜内皮和其他组织造成损伤的可能性与冲洗组织的冲洗液的化学成分、pH值和渗透压有关。质量平衡盐溶液(BSS)通常对角膜内皮正常的患者作为眼内溶液使用是安全的。如果预期冲洗时间延长,或者患者已经存在内皮失代偿,即原发性或继发性内皮病变,则建议使用“完全”BSS溶液以尽量减少损伤。眼内含亚硫酸盐的肾上腺素可能会导致严重的角膜水肿,应避免使用,或者如果使用,应充分稀释。现在有不含亚硫酸盐的肾上腺素溶液,不会引起含亚硫酸盐的肾上腺素溶液可能出现的内皮毒性。目前在手术中用作缩瞳剂的乙酰胆碱和卡巴胆碱制剂已在人体中进行了评估,对于内皮已经失代偿的患者,建议谨慎在眼内使用乙酰胆碱溶液。硫酸软骨素、羟丙基甲基纤维素和透明质酸钠在类似于人类白内障摘除的条件下对动物内皮细胞无毒,但如果与内皮持续接触数小时,则可能对内皮有毒性。硫酸软骨素已被证明在机械性人工晶状体创伤中具有更大的保护作用,可能是因为其粘性和覆盖内皮的倾向。粘弹性物质会使3% - 10%的患者眼内压显著升高> 30 mmHg。在术前有高眼压或青光眼病史的患者中,手术使用粘弹性物质后,术后经常会出现非常高的眼内压。